EQT makes $2.8 billion bid for drugmaker Recipharm

EQT makes $2.8 billion bid for drugmaker Recipharm

Buyout group EQT on Monday announced a cash offer for Swedish contract pharmaceutical maker Recipharm, valuing the company at $2.80 billion. Recipharm, a contract development and manufacturing organisation (CDMO) for the pharma industry, recently signed a preliminary...